Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): A multicentre, randomised, double-blind, placebo-controlled trial

Giora Weisz; Philippe Généreux; Andres Iñiguez; Aleksander Zurakowski; Michael Shechter; Karen P. Alexander; Ovidiu Dressler; Anna Osmukhina; Stefan James; E. Magnus Ohman; Ori Ben-Yehuda; Ramin Farzaneh-Far; Gregg W. Stone; RIVER-PCI investigators

doi:10.1016/S0140-6736(15)00459-6

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): A multicentre, randomised, double-blind, placebo-controlled trial

Giora Weisz^*
, Philippe Généreux
, Andres Iñiguez
, Aleksander Zurakowski
, Michael Shechter
, Karen P. Alexander
, Ovidiu Dressler
, Anna Osmukhina
, Stefan James
, E. Magnus Ohman
, Ori Ben-Yehuda
, Ramin Farzaneh-Far
, Gregg W. Stone
, RIVER-PCI investigators

^*Corresponding author for this work

Department of Internal Medicine 1 - Cardiology and Internal Critical Care

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	136-145
Number of pages	10
Journal	The Lancet
Volume	387
Issue number	10014
DOIs	https://doi.org/10.1016/S0140-6736(15)00459-6
Publication status	Published - 09 Jan 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Fields of science

302031 Intensive care medicine
302032 Cardiology
302030 Internal medicine

Access to Document

10.1016/S0140-6736(15)00459-6

Cite this

Weisz, G., Généreux, P., Iñiguez, A., Zurakowski, A., Shechter, M., Alexander, K. P., Dressler, O., Osmukhina, A., James, S., Ohman, E. M., Ben-Yehuda, O., Farzaneh-Far, R., Stone, G. W., & RIVER-PCI investigators (2016). Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): A multicentre, randomised, double-blind, placebo-controlled trial. The Lancet, 387(10014), 136-145. https://doi.org/10.1016/S0140-6736(15)00459-6

@article{1d92ce9d58804839b765b96d8e4b8ee9,

title = "Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): A multicentre, randomised, double-blind, placebo-controlled trial",

author = "Giora Weisz and Philippe G{\'e}n{\'e}reux and Andres I{\~n}iguez and Aleksander Zurakowski and Michael Shechter and Alexander, \{Karen P.\} and Ovidiu Dressler and Anna Osmukhina and Stefan James and Ohman, \{E. Magnus\} and Ori Ben-Yehuda and Ramin Farzaneh-Far and Stone, \{Gregg W.\} and \{RIVER-PCI investigators\}",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier Ltd.",

year = "2016",

month = jan,

day = "9",

doi = "10.1016/S0140-6736(15)00459-6",

language = "English",

volume = "387",

pages = "136--145",

journal = "The Lancet",

issn = "0140-6736",

number = "10014",

}

Weisz, G, Généreux, P, Iñiguez, A, Zurakowski, A, Shechter, M, Alexander, KP, Dressler, O, Osmukhina, A, James, S, Ohman, EM, Ben-Yehuda, O, Farzaneh-Far, R, Stone, GW & RIVER-PCI investigators 2016, 'Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): A multicentre, randomised, double-blind, placebo-controlled trial', The Lancet, vol. 387, no. 10014, pp. 136-145. https://doi.org/10.1016/S0140-6736(15)00459-6

TY - JOUR

T1 - Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI)

T2 - A multicentre, randomised, double-blind, placebo-controlled trial

AU - Weisz, Giora

AU - Généreux, Philippe

AU - Iñiguez, Andres

AU - Zurakowski, Aleksander

AU - Shechter, Michael

AU - Alexander, Karen P.

AU - Dressler, Ovidiu

AU - Osmukhina, Anna

AU - James, Stefan

AU - Ohman, E. Magnus

AU - Ben-Yehuda, Ori

AU - Farzaneh-Far, Ramin

AU - Stone, Gregg W.

AU - RIVER-PCI investigators

PY - 2016/1/9

Y1 - 2016/1/9

UR - https://www.scopus.com/pages/publications/84954077103

U2 - 10.1016/S0140-6736(15)00459-6

DO - 10.1016/S0140-6736(15)00459-6

M3 - Article

C2 - 26474810

AN - SCOPUS:84954077103

SN - 0140-6736

VL - 387

SP - 136

EP - 145

JO - The Lancet

JF - The Lancet

IS - 10014

ER -

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): A multicentre, randomised, double-blind, placebo-controlled trial

UN SDGs

Fields of science

Access to Document

Other files and links

Cite this